Rolf Kiessling

Utvalda publikationer

Mougiakakos, D.; Johansson, C. C.; Jitschin, R.; Bottcher, M.; Kiessling, R.

Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress.

Blood 2011, 117 (3), 857-61

Triulzi, C.; Vertuani, S.; Curcio, C.; Antognoli, A.; Seibt, J.; Akusjarvi, G.; Wei, W. Z.; Cavallo, F.; Kiessling, R.

Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.

Cancer Res 2010, 70 (19), 7431-41

Poschke, I.; Mougiakakos, D.; Hansson, J.; Masucci, G. V.; Kiessling, R.

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.

Cancer Res 2010, 70 (11), 4335-45

Mougiakakos, D.; Johansson, C. C.; Kiessling, R.

Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death.

Blood 2009, 113 (15), 3542-5

Norell, H.; Carlsten, M.; Ohlum, T.; Malmberg, K. J.; Masucci, G.; Schedvins, K.; Altermann, W.; Handke, D.; Atkins, D.; Seliger, B.; Kiessling, R.

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

Cancer Res 2006, 66 (12), 6387-94

Holmgren, L.; Ambrosino, E.; Birot, O.; Tullus, C.; Veitonmaki, N.; Levchenko, T.; Carlson, L. M.; Musiani, P.; Iezzi, M.; Curcio, C.; Forni, G.; Cavallo, F.; Kiessling, R

DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth.

Proc Natl Acad Sci U S A 2006, 103 (24), 9208-13

Choudhury, A.; Charo, J.; Parapuram, S. K.; Hunt, R. C.; Hunt, D. M.; Seliger, B.; Kiessling, R.

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

Int J Cancer 2004, 108 (1), 71-7

Nakagomi, H.; Petersson, M.; Magnusson, I.; Juhlin, C.; Matsuda, M.; Mellstedt, H.; Taupin, J. L.; Vivier, E.; Anderson, P.; Kiessling, R.

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

Cancer Res 1993, 53 (23), 5610-2

Kärre, K.; Ljunggren, H.-G.; Piontek, G. E.; Kiessling, R.

Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy.

Nature 1986, 319, 675-678

Kiessling, R.; Hochman, P. S.; Haller, O.; Shearer, G. M.; Wigzell, H.; Cudkowicz, G.

Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts.

Eur J Immunol 1977, 7 (9), 655-63

Kiessling, R.; Klein, E.; Pross, H.; Wigzell, H.

"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.

Eur J Immunol 1975, 5 (2), 117-21

Senast uppdaterad av: Monica Ringheim 2012-06-01